FAM171B as a Novel Biomarker Mediates Tissue Immune Microenvironment in Pulmonary Arterial Hypertension

The purpose of this study was to uncover potential diagnostic indicators of pulmonary arterial hypertension (PAH), evaluate the function of immune cells in the pathogenesis of the disease, and find innovative treatment targets and medicines with the potential to enhance prognosis. Gene Expression Om...

Full description

Bibliographic Details
Main Authors: Lai-Hao Qu, Wen-Juan Luo, Zhi-Guo Yan, Wen-Pan Liu
Format: Article
Language:English
Published: Hindawi Limited 2022-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2022/1878766
_version_ 1811181828030070784
author Lai-Hao Qu
Wen-Juan Luo
Zhi-Guo Yan
Wen-Pan Liu
author_facet Lai-Hao Qu
Wen-Juan Luo
Zhi-Guo Yan
Wen-Pan Liu
author_sort Lai-Hao Qu
collection DOAJ
description The purpose of this study was to uncover potential diagnostic indicators of pulmonary arterial hypertension (PAH), evaluate the function of immune cells in the pathogenesis of the disease, and find innovative treatment targets and medicines with the potential to enhance prognosis. Gene Expression Omnibus was utilized to acquire the PAH datasets. We recognized differentially expressed genes (DEGs) and investigated their functions utilizing R software. Weighted gene coexpression network analysis, least absolute shrinkage and selection operators, and support vector machines were used to identify biomarkers. The extent of immune cell infiltration in the normal and PAH tissues was determined using CIBERSORT. Additionally, the association between diagnostic markers and immune cells was analyzed. In this study, 258DEGs were used to analyze the disease ontology. Most DEGs were linked with atherosclerosis, arteriosclerotic cardiovascular disease, and lung disease, including obstructive lung disease. Gene set enrichment analysis revealed that compared to normal samples, results from PAH patients were mostly associated with ECM-receptor interaction, arrhythmogenic right ventricular cardiomyopathy, the Wnt signaling pathway, and focal adhesion. FAM171B was identified as a biomarker for PAH (area under the curve=0.873). The mechanism underlying PAH may be mediated by nave CD4 T cells, resting memory CD4 T cells, resting NK cells, monocytes, activated dendritic cells, resting mast cells, and neutrophils, according to an investigation of immune cell infiltration. FAM171B expression was also associated with resting mast cells, monocytes, and CD8 T cells. The results suggest that PAH may be closely related to FAM171B with high diagnostic performance and associated with immune cell infiltration, suggesting that FAM171B may promote the progression of PAH by stimulating immune infiltration and immune response. This study provides valuable insights into the pathogenesis and treatment of PAH.
first_indexed 2024-04-11T09:23:30Z
format Article
id doaj.art-4c9cce876c8f4ed08fb3636a8102fad3
institution Directory Open Access Journal
issn 1466-1861
language English
last_indexed 2024-04-11T09:23:30Z
publishDate 2022-01-01
publisher Hindawi Limited
record_format Article
series Mediators of Inflammation
spelling doaj.art-4c9cce876c8f4ed08fb3636a8102fad32022-12-22T04:32:06ZengHindawi LimitedMediators of Inflammation1466-18612022-01-01202210.1155/2022/1878766FAM171B as a Novel Biomarker Mediates Tissue Immune Microenvironment in Pulmonary Arterial HypertensionLai-Hao Qu0Wen-Juan Luo1Zhi-Guo Yan2Wen-Pan Liu3Cardiothoracic SurgeryDepartment of CardiologyCardiothoracic SurgeryCardiothoracic SurgeryThe purpose of this study was to uncover potential diagnostic indicators of pulmonary arterial hypertension (PAH), evaluate the function of immune cells in the pathogenesis of the disease, and find innovative treatment targets and medicines with the potential to enhance prognosis. Gene Expression Omnibus was utilized to acquire the PAH datasets. We recognized differentially expressed genes (DEGs) and investigated their functions utilizing R software. Weighted gene coexpression network analysis, least absolute shrinkage and selection operators, and support vector machines were used to identify biomarkers. The extent of immune cell infiltration in the normal and PAH tissues was determined using CIBERSORT. Additionally, the association between diagnostic markers and immune cells was analyzed. In this study, 258DEGs were used to analyze the disease ontology. Most DEGs were linked with atherosclerosis, arteriosclerotic cardiovascular disease, and lung disease, including obstructive lung disease. Gene set enrichment analysis revealed that compared to normal samples, results from PAH patients were mostly associated with ECM-receptor interaction, arrhythmogenic right ventricular cardiomyopathy, the Wnt signaling pathway, and focal adhesion. FAM171B was identified as a biomarker for PAH (area under the curve=0.873). The mechanism underlying PAH may be mediated by nave CD4 T cells, resting memory CD4 T cells, resting NK cells, monocytes, activated dendritic cells, resting mast cells, and neutrophils, according to an investigation of immune cell infiltration. FAM171B expression was also associated with resting mast cells, monocytes, and CD8 T cells. The results suggest that PAH may be closely related to FAM171B with high diagnostic performance and associated with immune cell infiltration, suggesting that FAM171B may promote the progression of PAH by stimulating immune infiltration and immune response. This study provides valuable insights into the pathogenesis and treatment of PAH.http://dx.doi.org/10.1155/2022/1878766
spellingShingle Lai-Hao Qu
Wen-Juan Luo
Zhi-Guo Yan
Wen-Pan Liu
FAM171B as a Novel Biomarker Mediates Tissue Immune Microenvironment in Pulmonary Arterial Hypertension
Mediators of Inflammation
title FAM171B as a Novel Biomarker Mediates Tissue Immune Microenvironment in Pulmonary Arterial Hypertension
title_full FAM171B as a Novel Biomarker Mediates Tissue Immune Microenvironment in Pulmonary Arterial Hypertension
title_fullStr FAM171B as a Novel Biomarker Mediates Tissue Immune Microenvironment in Pulmonary Arterial Hypertension
title_full_unstemmed FAM171B as a Novel Biomarker Mediates Tissue Immune Microenvironment in Pulmonary Arterial Hypertension
title_short FAM171B as a Novel Biomarker Mediates Tissue Immune Microenvironment in Pulmonary Arterial Hypertension
title_sort fam171b as a novel biomarker mediates tissue immune microenvironment in pulmonary arterial hypertension
url http://dx.doi.org/10.1155/2022/1878766
work_keys_str_mv AT laihaoqu fam171basanovelbiomarkermediatestissueimmunemicroenvironmentinpulmonaryarterialhypertension
AT wenjuanluo fam171basanovelbiomarkermediatestissueimmunemicroenvironmentinpulmonaryarterialhypertension
AT zhiguoyan fam171basanovelbiomarkermediatestissueimmunemicroenvironmentinpulmonaryarterialhypertension
AT wenpanliu fam171basanovelbiomarkermediatestissueimmunemicroenvironmentinpulmonaryarterialhypertension